Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.35 |
| ▸ | CETP | P11597 | 4/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14678814 | 0.78 | TSHR (0.48) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL483610 | 0.78 | TSHR (0.48) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL483452 | 0.75 | ALDH1A1 (0.45) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL27776361 | 0.73 | TSHR (0.42) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL5161553 | 0.72 | TSHR (0.42) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL483453 | 0.72 | TDP1 (0.42) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL422328 | 0.71 | ZDHHC20 (0.50) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| Phosphoric Acid SCHEMBL28573485 | 0.70 | TSHR (0.52) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL21091697 | 0.69 | TSHR (0.47) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL34047 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097126-B2 | Aqueous composition and use thereof for paper production | BASF SE (DE) | 2012-01-17 | — | — | US | claimed |
| EP-1654419-B1 | AQUEOUS COMPOSITION AND USE THEREOF FOR PAPER PRODUCTION | BASF AG (DE) | 2006-11-08 | — | — | EP | claimed |
| US-20060037725-A1 | Aqueous composition and use thereof for paper production | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-23 | — | — | US | claimed |
| US-20060024262-A1 | Aqueous composition and use thereof for paper production | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-02 | — | — | US | claimed |
| WO-2025111425-A1 | A METHOD OF PRODUCING VINYLAMINE-CONTAINING POLYMERS | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | disclosed |
| WO-2025111424-A1 | PARTICULATE VINYLAMINE COMPOSITIONS AND METHOD OF MAKING | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | disclosed |
| WO-2025111428-A1 | METHOD FOR PRODUCTION OF VINYL CARBOXAMIDE CONTAINING POLYMERS IN PARTICULATE FORM | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | disclosed |
| US-20250163194-A1 | METHOD OF PRODUCING VINYLAMINE-CONTAINING POLYMERS | SOLENIS TECHNOLOGIES, L.P. (US) | 2025-05-22 | — | — | US | disclosed |
| US-20250163647-A1 | METHOD FOR PRODUCTION OF VINYL CARBOXAMIDE CONTAINING POLYMERS IN PARTICULATE FORM | SOLENIS TECHNOLOGIES, L.P. (US) | 2025-05-22 | — | — | US | disclosed |
| US-20250163646-A1 | PARTICULATE VINYLAMINE COMPOSITIONS AND METHOD OF MAKING | SOLENIS TECHNOLOGIES, L.P. (US) | 2025-05-22 | — | — | US | disclosed |
| WO-2024132736-A1 | PROCESS FOR MANUFACTURING A MULTI-LAYER PAPER OR CARDBOARD | BASF SE (DE) | 2024-06-27 | — | — | WO | disclosed |
| EP-3697964-B1 | METHOD FOR THE PREPARATION OF SINGLE LAYER OR MULTI-LAYER PAPER | SOLENIS TECHNOLOGIES CAYMAN LP (KY) | 2024-06-26 | — | — | EP | disclosed |
| US-8227529-B2 | Aqueous slurries of finely divided fillers, a process for their preparation and their use for the production of papers having a high filler content and high dry strength | BASF SE (DE) | 2012-07-24 | — | — | US | disclosed |
| US-8097126-B2 | Aqueous composition and use thereof for paper production | BASF SE (DE) | 2012-01-17 | — | — | US | disclosed |
| US-20110132559-A1 | PROCESS FOR INCREASING THE DRY STRENGTH OF PAPER, BOARD AND CARDBOARD | BASF SE (DE) | 2011-06-09 | — | — | US | disclosed |
| US-20110079365-A1 | PRODUCTION OF PAPER | BASF SE (DE) | 2011-04-07 | — | — | US | disclosed |
| US-20100181037-A1 | AQUEOUS SLURRIES OF FINELY DIVIDED FILLERS, A PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THE PRODUCTION OF PAPERS HAVING A HIGH FILLER CONTENT AND HIGH DRY STRENGTH | BASF SE (DE) | 2010-07-22 | — | — | US | disclosed |
| US-20100179248-A1 | AQUEOUS SLURRIES OF FINELY DIVIDED FILLERS, A PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THE PRODUCTION OF PAPERS HAVING A HIGH FILLER CONTENT AND HIGH DRY STRENGTH | BASF SE (DE) | 2010-07-15 | — | — | US | disclosed |
| US-20060037725-A1 | Aqueous composition and use thereof for paper production | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-23 | — | — | US | disclosed |
| US-20060024262-A1 | Aqueous composition and use thereof for paper production | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060024262-A1 | Aqueous composition and use thereof for paper production | CHMP4B, AQP1, IL17A | TSHR 4840/4885ALDH1A1 3860/4885MAPK1 1098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.